Tillotts Pharma is a company dedicated to the development, in/out-licensing, and commercialization of pharmaceutical products for the digestive system. It offers therapeutics for inflammatory bowel disease, ulcerative colitis, Crohn's disease, microscopic colitis, irritable bowel syndrome, and colorectal cancer.